Dr. Lal Pathlabs

BSE: 539524 | NSE: LALPATHLAB | ISIN: INE600L01024 | SECTOR: Healthcare Facilities

₹ 2,331.40

14.45 (0.62%)
06 May 2024, 03:29 PM IST
View all metrics

Key Metrics

Influencer Count

-

Simple Moving Averages

DaysBSENSE

52,343.742,343.28
102,307.752,308.03
202,300.002,300.21
502,278.532,278.85
1002,403.052,403.66
3002,409.322,409.92

News

View all

Company Description

Dr. Lal PathLabs Limited is an India-based company that is engaged in providing diagnostic and related healthcare tests and services. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, and viral infections. The Company’s subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, and Dr. Lal PathLabs Nepal Private Limited.

Company Officers